Improvement of HIV-related pulmonary hypertension after the introduction of an antiretroviral therapy

European Respiratory Journal

Volumn 34, Issue 1, 2009, Pages 277-278

  Barnier, A ^a   Frachon, I ^a,b   Dewilde, J ^a   Gut Gobert, C ^a   Jobic, Y ^a   Leroyer, C ^a  

^a Hopital Universitaire de la Cavale Blanche   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BOSENTAN; DIURETIC AGENT; EMTRICITABINE; LOPINAVIR; PROSTACYCLIN; RITONAVIR; TENOFOVIR DISOPROXIL;

ADD ON THERAPY; ADULT; CASE REPORT; DRUG DOSE INCREASE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION, PULMONARY; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 69249141822     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00014209     Document Type: Letter

References (10)

1. Sitbon O, Lascoux-Combe C, Delfraissy JF, et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med 2008; 177: 108-113.
2. Sitbon O, Gressin V, Speich R, et al. Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2004; 170: 1212-1217.
3. Zuber JP, Calmy A, Evison JM, et al. Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 2004; 38: 1178-1185.
4. Sitbon O. HIV-related pulmonary hypertension: clinical presentation and management. AIDS 2008; 22: Suppl. 3, S55-S62.
5. Feiterna-Sperling C, Huseman D, Timme J, et al. Resolution of human immunodeficiency virus type 1 infection-related severe pulmonary hypertension in a very low-birth-weight infant. Pediatr Infect Dis J 2008; 27: 564-567.
6. Speich R, Jenni R, Opravil M, et al. Regression of HIV-associated pulmonary arterial hypertension and long-term survival during antiretroviral therapy. Swiss Med Wkly 2001; 131: 663-665.
7. Pellicelli AM, Barbaro G, Palmieri F, et al. Primary pulmonary hypertension in HIV patients: a systematic review. Angiology 2001; 52: 31-41.
8. Pellicelli AM, D'Ambrosio C, Vizza CD, et al. HIV-related pulmonary hypertension. From pathogenesis to clinical aspects. Acta Cardiol 2004; 59: 323-330.
9. Barbaro G, Lucchini A, Pellicelli AM, et al. Highly active antiretroviral therapy compared with HAART and bosentan in combination in patients with HIV-associated pulmonary hypertension. Heart 2006; 92: 1164-1166.
10. Torre D, Pugliese A. Impact of antiretroviral therapy among HIV-1-infected patients with pulmonary hypertension. Clin Infect Dis 2004; 39: 1549-1550.